Trademark: 79287747
Status Date
Tuesday, July 13, 2021
Registration Number
6413534
Registration Date
Tuesday, July 13, 2021
Filing Date
Monday, April 20, 2020
Published for Opposition
Tuesday, April 27, 2021
40 Custom manufacturing services in the field of drug delivery patches; custom manufacture of medical devices, pharmaceuticals, diagnostic tests and testing kits; custom manufacture of micro-projection array patches; custom manufacture of drug delivery devices and apparatus; custom manufacture of transdermal drug delivery devices and apparatus; custom manufacture of intradermal drug delivery devices and apparatus; custom manufacture of micro-projection drug delivery devices and apparatus; advisory, consultancy and information services in relation to all of the aforesaid
5 Pharmaceutical, medicinal and therapeutic preparations for human and veterinary use for the treatment of infectious disease, allergies and oncology; vaccines; vaccine preparations; diagnostic preparations for medical or veterinary purposes; biological specimens, blood and plasma for human medical diagnostics and analysis; transdermal patches, bandages, poultices and medical dressings impregnated with vaccines; patches, bandages, poultices and medical dressings impregnated with vaccines; transdermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations for treating infectious disease, allergies and oncology contained in transdermal patches; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of infectious disease, allergies and oncology; transdermal patches for administering pharmaceuticals for use in the treatment of infectious disease, allergies and oncology and vaccines; intradermal patches for use in the medical treatment of infectious disease, allergies and oncology; intradermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations contained in intradermal patches for use in the medical treatment of infectious disease, allergies and oncology; skin patches for the intradermal delivery of pharmaceuticals for use in the treatment of infectious disease, allergies and oncology; intradermal patches for medical treatment for administering pharmaceuticals for use in the medical treatment of infectious disease, allergies and oncology and vaccines; micro-projection array patches for medical purposes impregnated with vaccines; structural parts and fittings for the aforesaid goods
45 Legal services relating to the exploitation and licensing of intellectual property and technology; licensing of medical technology; legal services relating to the licensing of research and development of products; advisory, consultancy and information services in relation to all of the aforesaid
44 Medical, medical clinic, and healthcare services relating to vaccines; medical and veterinary consultancy; medical testing for diagnostic or treatment purposes; advisory, consultancy and information services in relation to all of the aforesaid
10 Surgical and medical apparatus and instruments, namely, vaccine and drug delivery microneedle array patches sold without medication; drug delivery devices and apparatus, namely, hermetically sealed applicators containing patches for applying vaccine sold without medication; drug delivery devices sold empty, namely, uncoated patches sold without medication; transdermal drug delivery devices and apparatus, namely, transdermal drug delivery patches sold without medication; intradermal drug delivery devices and apparatus, namely, intradermal drug delivery patches sold without medication; micro-projection drug delivery devices and apparatus, namely, drug delivery patches sold without medication; structural parts and fittings for the aforesaid goods
42 Research, design and development services in the field of medical apparatus and instruments; medical research, design and development services in the field of drug delivery devices; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; drug discovery; vaccine screening, namely, safety testing of vaccines; scientific and technological research services related to immunopharmaceuticals and vaccines; biological research, clinical research in the field of immunology, vaccines, and medical research; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical and biochemical analysis services; medical and scientific research; pharmaceutical research services; laboratory testing services in the field of vaccines, pharmaceuticals; laboratory research in the fields of biotechnology, microbiology, molecular biology, nanotechnology analytical chemistry, biochemistry, medicinal chemistry and drug development; technology services, namely, design and development of computer hardware; scientific research, clinical research, development, advisory and consultancy services in relation to antibody production; research and development services in the field of antibodies; antibody generation services being research and development services; diagnostic and research services and screening in the field of infectious disease, allergies and oncology for medical research purposes; diagnostic testing services in the field of medical apparatus and instruments; medical research services; advisory services relating to diagnostic testing of products for quality control and safety purposes; research and development of products; advisory, consultancy and information services in relation to all of the aforesaid
In the statement, Column 2, lines 3 and 4, "Sydney N AUSTRALIA" should be deleted, and "Sydney, NSW AUSTRALIA 2000" should be inserted.
Oct 10, 2023
Notice Of Updated Registration Confirmation Emailed
Sep 5, 2023
Correction Under Section 7 ¿ Processed
Aug 30, 2023
Case Assigned To Post Registration Paralegal
Mar 25, 2022
Case Assigned To Post Registration Paralegal
Mar 25, 2022
Correction Under Section 7 ¿ Processed
Mar 24, 2022
Case Assigned To Post Registration Paralegal
Nov 28, 2021
Final Decision Transaction Processed By Ib
Nov 9, 2021
Final Disposition Notice Sent To Ib
Nov 9, 2021
Final Disposition Processed
Oct 31, 2021
Teas Section 7 Request Received
Oct 13, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jul 13, 2021
Registered-Principal Register
Apr 27, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 27, 2021
Published For Opposition
Apr 24, 2021
Notification Processed By Ib
Apr 7, 2021
Notification Of Possible Opposition Sent To Ib
Apr 7, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 7, 2021
Notification Of Notice Of Publication E-Mailed
Mar 23, 2021
Approved For Pub - Principal Register
Mar 23, 2021
Teas/Email Correspondence Entered
Mar 22, 2021
Correspondence Received In Law Office
Mar 22, 2021
Teas Request For Reconsideration Received
Mar 17, 2021
Notification Of Final Refusal Emailed
Mar 17, 2021
Final Refusal E-Mailed
Mar 17, 2021
Final Refusal Written
Feb 24, 2021
Teas/Email Correspondence Entered
Feb 23, 2021
Correspondence Received In Law Office
Feb 23, 2021
Teas Response To Office Action Received
Sep 10, 2020
Notification Of Non-Final Action E-Mailed
Sep 10, 2020
Non-Final Action E-Mailed
Sep 10, 2020
Non-Final Action Written
Aug 30, 2020
Refusal Processed By Ib
Aug 20, 2020
Teas/Email Correspondence Entered
Aug 19, 2020
Correspondence Received In Law Office
Aug 19, 2020
Teas Response To Office Action Received
Aug 11, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Aug 11, 2020
Refusal Processed By Mpu
Jul 20, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Jul 19, 2020
Non-Final Action Written
Jul 11, 2020
Assigned To Examiner
Jun 24, 2020
Application Filing Receipt Mailed
Jun 20, 2020
New Application Office Supplied Data Entered
Jun 18, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
